Evidence map›Paper›PMID 40059680›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2025

[Clinical characteristics and prognostic analysis of newly diagnosed acute myeloid leukemia with critical illness].

P Q Liang, M Gao, Y Xie, B Q Li, Q Li, Z Y Liu, D Wang, H Y Qiu, S N Chen, D P Wu and 1 more

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

P Q LiangNational Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Department of Hematology, Intensive Care Unit, Jiangsu Institute of Hematology, Suzhou 215006, China.
M GaoNational Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Department of Hematology, Intensive Care Unit, Jiangsu Institute of Hematology, Suzhou 215006, China.
Y XieNational Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Department of Hematology, Intensive Care Unit, Jiangsu Institute of Hematology, Suzhou 215006, China.
B Q LiNational Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Department of Hematology, Intensive Care Unit, Jiangsu Institute of Hematology, Suzhou 215006, China.
Q LiNational Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Department of Hematology, Intensive Care Unit, Jiangsu Institute of Hematology, Suzhou 215006, China.
Z Y LiuNational Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Department of Hematology, Intensive Care Unit, Jiangsu Institute of Hematology, Suzhou 215006, China.
D WangNational Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Department of Hematology, Intensive Care Unit, Jiangsu Institute of Hematology, Suzhou 215006, China.
H Y QiuNational Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Department of Hematology, Intensive Care Unit, Jiangsu Institute of Hematology, Suzhou 215006, China.
S N ChenNational Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Department of Hematology, Intensive Care Unit, Jiangsu Institute of Hematology, Suzhou 215006, China.
D P WuNational Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Department of Hematology, Intensive Care Unit, Jiangsu Institute of Hematology, Suzhou 215006, China.
J H FuNational Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Department of Hematology, Intensive Care Unit, Jiangsu Institute of Hematology, Suzhou 215006, China.

Funding

Beijing Bethune Charitable Foundation 2022-YJ-085-J-Z-ZZ-022Horizontal Subject of Soochow University H211284
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Critical IllnessLeukemia, Myeloid, AcuteAdultAgedFemaleHumansIntensive Care UnitsMaleMiddle AgedPrognosisRetrospective StudiesRisk FactorsCritical illnessEarly deathIntensive care unitLeukemia, myeloid, acute

Identifiers

PMID40059680
PMCPMC11886432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.